Ceftizoxime + Sulbactum 1.5gm

What is Ceftizoxime + Sulbactam Injection 1.5 g?

Ceftizoxime + Sulbactam Injection is described as a combination injectable antibacterial product containing ceftizoxime and sulbactam. Ceftizoxime is a cephalosporin antibiotic, while sulbactam is a beta-lactamase inhibitor. The suitability of this combination depends on the approved formulation, the susceptibility of the causative organism and clinical assessment. The stated 1.5 g strength requires confirmation of the individual component quantities.

Uses / Indications

The intended use of this combination should be determined from the approved product information and clinical assessment. Antibiotic treatment should be selected according to the suspected or confirmed infection, susceptibility results and patient-specific factors.

Benefits

• Combines a cephalosporin-class antibiotic with a beta-lactamase inhibitor.

• May offer an injectable treatment option where the approved formulation is appropriate.

• Supports treatment decisions guided by bacterial susceptibility and professional assessment.

Side Effects

Possible adverse effects depend on the formulation, dose and individual patient.

Common side effects

• Nausea or vomiting

• Diarrhoea

• Skin rash

• Injection-site discomfort

Less common or serious side effects

• Severe allergic reactions, including anaphylaxis

• Severe or persistent diarrhoea

• Serious skin reactions

• Changes in liver function or blood cell counts

Seek urgent medical attention if signs of a severe allergic reaction or another serious adverse effect occur.

How Does It Work?

Ceftizoxime inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins, which can lead to bacterial cell death. Sulbactam inhibits certain beta-lactamase enzymes that can break down some beta-lactam antibiotics. The clinical contribution of each component depends on the specific formulation and susceptibility of the infecting organism.

Dosage Guidelines

The appropriate dose and duration depend on the infection, its severity, patient age, kidney function, bacterial susceptibility and the approved formulation.

The exact dose, administration route, frequency and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

Preparation and administration must follow the approved instructions for the specific product. Confirm the individual component strengths and supplied WFI configuration before use.

When Not to Use

• In patients with a known serious hypersensitivity to ceftizoxime, sulbactam or any product component.

• In patients with a history of severe reactions to cephalosporins or other beta-lactam antibiotics, unless a qualified healthcare professional has assessed the risks and suitability of treatment.

Drug / Product Interactions

Potential interactions and precautions may include:

• Other antibiotics: Concurrent treatment should be determined by the clinical indication and approved guidance.

• Medicines affecting kidney function: Additional monitoring may be necessary in patients with renal impairment or concurrent medicines that affect renal function.

• Anticoagulants: Monitoring may be appropriate depending on the patient’s medication and clinical circumstances.

• Other prescribed medicines: A healthcare professional should review the complete medication list before treatment.

Product-specific interaction information should be checked against the approved prescribing information.

Safety Advice

• Use only under the supervision of a qualified healthcare professional.

• Review the patient’s allergy history before administration.

• Use antibiotics only for appropriate bacterial infections.

• Follow approved preparation, administration and infection-control procedures.

• Monitor for allergic reactions and other clinically significant adverse effects.

General Instructions

• Verify the product name, ingredient identity, individual component strengths and total strength before use.

• Follow the approved instructions for preparation and administration.

• Do not use damaged packaging or a vial that does not meet the required specifications.

• Confirm storage conditions and instructions for use after preparation from the approved product label.

Special Dietary / Lifestyle Tips

No specific diet can be recommended solely on the basis of the product name. Patients should follow their healthcare professional’s advice, maintain adequate hydration when appropriate and adhere to the prescribed treatment plan.

Comparison with Other Treatments

Ceftizoxime is a cephalosporin antibiotic, while sulbactam is a beta-lactamase inhibitor. The suitability of this combination compared with other antibiotics depends on the approved formulation, organism susceptibility, infection site, local resistance patterns and patient-specific factors. Antibiotic combinations should not be considered interchangeable without clinical assessment.

Precautions & Warnings

• Allergy risk: Confirm any previous reactions to cephalosporins, penicillins or other beta-lactam antibiotics.

• Kidney function: Renal impairment may affect dosing requirements.

• Antibiotic resistance: Inappropriate use can contribute to antimicrobial resistance.

• Superinfection: Prolonged or inappropriate antibiotic treatment may allow non-susceptible organisms to grow.

• Product verification: Confirm the ingredient spelling, individual component quantities and approved formulation before use.

Can I Use It With Other Medicines?

Generally Compatible With

Other medicines may be used when clinically indicated, subject to review by the treating healthcare professional and the approved product information.

Use With Caution

• Other antibiotics used as part of combination treatment

• Medicines that may affect kidney function

• Anticoagulants or medicines requiring additional laboratory monitoring

Avoid

Avoid use in patients with a known serious hypersensitivity to any active ingredient or relevant product component. Do not mix the product with other medicines in the same syringe or infusion container unless compatibility is established by the approved product information.

Storage

Store according to the conditions stated on the approved product label. Follow product-specific instructions for preparation, handling and use after reconstitution. Do not assume a storage temperature or post-preparation shelf life without verified product information.

Frequently Asked Questions

1. What is Ceftizoxime + Sulbactam Injection 1.5 g?

It is described as a combination injectable antibacterial product. The approved formulation and intended indications should be confirmed before use.

2. Which ingredients are listed?

The supplied product name lists ceftizoxime and sulbactam. The spelling and identity of each ingredient should be verified against the approved specification.

3. What does the 1.5 g strength mean?

The supplied description states a total strength of 1.5 g. The individual quantities of ceftizoxime and sulbactam need confirmation.

4. Does the product come with WFI?

The supplied description specifies a 1.5 g vial with WFI. Confirm the exact presentation and preparation instructions against the approved product specification.

5. Can it treat viral infections?

Antibiotics are intended for susceptible bacterial infections, not viral illnesses such as colds or influenza.

6. What precautions are important before administration?

Confirm the ingredient identity, approved component strengths, allergy history, kidney function where relevant and product-specific preparation instructions.

7. Who should administer the injection?

A qualified healthcare professional should prepare and administer the product according to its approved instructions.

8. Can Kelar Pharmachem India support sourcing enquiries?

Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries. Product specifications, supporting documentation and destination-market requirements are subject to confirmation.